Thrive Capital Management (Pennsylvania)’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-1,927
Closed -$298K – 138
2023
Q1
$298K Sell
1,927
-843
-30% -$126K 0.19% 89
2022
Q4
$389K Buy
2,770
+137
+5% +$19.4K 0.25% 75
2022
Q3
$338K Buy
2,633
+905
+52% +$131K 0.23% 75
2022
Q2
$244K Buy
+1,728
New +$247K 0.17% 92

Other funds holding CLX

Thrive Capital Management (Pennsylvania)'s CLX Position: Q2 2023 in Review

Thrive Capital Management (Pennsylvania) sold out of Clorox (CLX) in Q2 2023, closing a stake of 1,927 shares — an estimated $298K sold.

Thrive Capital Management (Pennsylvania) first reported a position in CLX in Q2 2022 and held it in 4 quarters. The position peaked at $389K in Q4 2022. 1,143 funds tracked by Wall St. Rank hold CLX as of Q2 2023.

  • Thrive Capital Management (Pennsylvania) reported no remaining Clorox position as of Q2 2023 after selling out during the quarter.
  • Thrive Capital Management (Pennsylvania) sold 1,927 Clorox shares in Q2 2023, an estimated $298K.
  • Thrive Capital Management (Pennsylvania) first reported a position in Clorox in Q2 2022 and held it in 4 quarters.
  • Thrive Capital Management (Pennsylvania)'s Clorox position peaked at $389K in Q4 2022.
  • 1,143 funds tracked by Wall St. Rank held Clorox as of Q2 2023.

Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q2 2023, filed 2 Aug 2023.